Hematology
Model Better Predicts Lung Cancer Risk for African Americans
TUESDAY, Sept. 1, 2020 (HealthDay News) — The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Model 2012 (PLCOm2012) risk prediction model is more sensitive for identifying African American ever-smokers for lung cancer screening than the U.S. Preventive Services Task Force (USPSTF) criteria, according to a study published online Aug. 18 in the Journal of...
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
MONDAY, Aug. 31, 2020 (HealthDay News) — A deep learning model based on chest radiograph (CXR) images and data from the electronic medical record (EMR) has better discrimination for smokers at high risk for incident lung cancer than Centers for Medicare & Medicaid Services (CMS) eligibility, according to a study published online Sept. 1 in...
Risk for Cancer Reduced for Patients With Multiple Sclerosis
FRIDAY, Aug. 28, 2020 (HealthDay News) — The risk for cancer is reduced among patients with multiple sclerosis (MS), according to a systematic review and meta-analysis published online Aug. 13 in Autoimmunity Reviews. Mahsa Ghajarzadeh, M.D., M.P.H., from the Tehran University of Medical Sciences in Iran, and colleagues examined the pooled risk for cancer in...
Sickle Cell Disease Treatment Options
Sickle cell disease (SCD) is the most common genetic disease affecting 100,000 people in the U.S. According to the CDC 1 out of 365 African Americans and 1 out of 16,300 Hispanic- Americans have sickle cell disease. The majority of SCD patients are medicaid beneficiaries (less than 70% of doctors in the U.S. accept new...
Diagnosing Chronic Lymphocytic Leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is a cancer that occurs when the bone marrow makes too many lymphocytes, a type of white blood cell. CLL usually grows slowly compared to other leukemias, and it may not cause symptoms for some time. CLL is one of four main types of leukemia. It is the second most common...
Research Sheds Light on Ethnic Discrepancies in CLL
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in the United States. In fact, it is often considered a disease primarily isolated to the Western world. There are remarkable patterns in the incidence of the disease among ethnicities. It most commonly appears in Caucasian individuals and markedly less so in non-Caucasians. For...
Report: Social Determinants Must Be Addressed to Advance Health Equity
Although the overall rate of people dying from cancer in the United States has dropped 27% in the past 25 years, some disadvantaged populations didn’t see the same decline. “We’re making progress against cancer in the United States, but some groups aren’t benefitting as much as others,” said Kassandra Alcaraz, PhD, MPH. “Health is affected...
FDA Approves Oxbryta, Second Sickle Cell Drug Approval in 10 Days
On Monday November 25 the U.S. Food and Drug Administration granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older. “Today’s approval provides additional hope to the 100,000 people in the U.S., and the more than 20 million globally, who...
Dr. Edward Ivy: Improving Access to Care in Sickle Cell Disease
I have lived with sickle cell disease for 48 years. The toll it takes goes far beyond pain – it has impacted me emotionally, economically, and psychosocially. I missed childhood activities because I was too sick or tired. I missed school days and worked harder to catch up on missed assignments. I learned to live...
More Medical News
